Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JULLIUS I ANCHETA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1225146350
CMS profile
55348
Location
VENICE, FL

General Payments · PY2018–2024

$2,553.40

  • Reported across 152 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$745.35

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $745.35 38

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $236.58 13
PFIZER INC. $107.93 5
Lilly USA, LLC $86.84 4
EISAI INC. $57.37 3
UCB, Inc. $56.69 2
Biogen, Inc. $42.54 2
ARGENX US, INC. $34.34 2
Teva Pharmaceuticals USA, Inc. $33.64 2
ACADIA Pharmaceuticals Inc $25.06 1
Amneal Pharmaceuticals LLC $17.98 1
Grifols USA, LLC $16.72 1
Acorda Therapeutics, Inc $15.18 1
Lundbeck LLC $14.48 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $602.50 47
PY2019 $486.64 34
PY2020 $244.84 9
PY2023 $474.07 24
PY2024 $745.35 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920202023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $8.97 01/30/2024 Food and Beverage Undisputed 01/23/2026 1103222149 CMS
ABBVIE INC. $23.37 02/05/2024 Food and Beverage Undisputed 01/23/2026 1103222151 CMS
ABBVIE INC. $22.28 02/08/2024 Food and Beverage Undisputed 01/23/2026 1103222153 CMS
ABBVIE INC. $10.20 02/28/2024 Food and Beverage Undisputed 01/23/2026 1103222155 CMS
ABBVIE INC. $19.74 03/05/2024 Food and Beverage Undisputed 01/23/2026 1103222157 CMS
ABBVIE INC. $11.71 03/14/2024 Food and Beverage Undisputed 01/23/2026 1103222159 CMS
ABBVIE INC. $27.11 04/05/2024 Food and Beverage Undisputed 01/23/2026 1103222161 CMS
ABBVIE INC. $17.91 05/28/2024 Food and Beverage Undisputed 01/23/2026 1103222163 CMS
ABBVIE INC. $21.10 05/30/2024 Food and Beverage Undisputed 01/23/2026 1103222165 CMS
ABBVIE INC. $28.53 07/12/2024 Food and Beverage Undisputed 01/23/2026 1103222167 CMS
ABBVIE INC. $20.52 07/18/2024 Food and Beverage Undisputed 01/23/2026 1103222169 CMS
ABBVIE INC. $10.29 07/23/2024 Food and Beverage Undisputed 01/23/2026 1103222171 CMS
ABBVIE INC. $14.85 09/03/2024 Food and Beverage Undisputed 01/23/2026 1103222173 CMS
ACADIA Pharmaceuticals Inc $25.06 06/05/2024 Food and Beverage Undisputed 01/23/2026 1147961947 CMS
Acorda Therapeutics, Inc $15.18 02/06/2024 Food and Beverage Undisputed 01/23/2026 1142348736 CMS
Amneal Pharmaceuticals LLC $17.98 10/31/2024 Food and Beverage Undisputed 01/23/2026 1139179075 CMS
ARGENX US, INC. $17.92 01/23/2024 Food and Beverage Undisputed 01/23/2026 1142102460 CMS
ARGENX US, INC. $16.42 10/03/2024 Food and Beverage Undisputed 01/23/2026 1142119913 CMS
Biogen, Inc. $22.25 03/19/2024 Food and Beverage Undisputed 01/23/2026 1104871764 CMS
Biogen, Inc. $20.29 05/23/2024 Food and Beverage Undisputed 01/23/2026 1104817892 CMS
Eisai Inc. $19.60 02/14/2024 Food and Beverage Undisputed 01/23/2026 1110756448 CMS
Eisai Inc. $17.00 08/22/2024 Food and Beverage Undisputed 01/23/2026 1110756450 CMS
Eisai Inc. $20.77 11/12/2024 Food and Beverage Undisputed 01/23/2026 1110756452 CMS
Grifols USA, LLC $16.72 08/13/2024 Food and Beverage Undisputed 01/23/2026 1124733113 CMS
Lilly USA, LLC $20.35 01/18/2024 Food and Beverage Undisputed 01/23/2026 1135087106 CMS
Lilly USA, LLC $21.73 06/25/2024 Food and Beverage Undisputed 01/23/2026 1135114732 CMS
Lilly USA, LLC $16.37 09/05/2024 Food and Beverage Undisputed 01/23/2026 1135111876 CMS
Lilly USA, LLC $28.39 11/14/2024 Food and Beverage Undisputed 01/23/2026 1135114734 CMS
Lundbeck LLC $14.48 08/15/2024 Food and Beverage Undisputed 01/23/2026 1145891853 CMS
PFIZER INC. $24.78 01/09/2024 Food and Beverage Undisputed 01/23/2026 1131116873 CMS
PFIZER INC. $16.02 03/14/2024 Food and Beverage Undisputed 01/23/2026 1131116877 CMS
PFIZER INC. $22.12 03/28/2024 Food and Beverage Undisputed 01/23/2026 1131256675 CMS
PFIZER INC. $29.90 07/09/2024 Food and Beverage Undisputed 01/23/2026 1131667873 CMS
PFIZER INC. $15.11 07/23/2024 Food and Beverage Undisputed 01/23/2026 1131749538 CMS
Teva Pharmaceuticals USA, Inc. $13.08 07/11/2024 Food and Beverage Undisputed 01/23/2026 1151738411 CMS
Teva Pharmaceuticals USA, Inc. $20.56 10/01/2024 Food and Beverage Undisputed 01/23/2026 1151738467 CMS
UCB, Inc. $27.15 02/01/2024 Food and Beverage Undisputed 01/23/2026 1143385202 CMS
UCB, Inc. $29.54 08/27/2024 Food and Beverage Undisputed 01/23/2026 1143385206 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.